(Reuters) - The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine.
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine.